analyst
AN
NASDAQ · ANVS
Annovis Bio, Inc.
Healthcare · Biotechnology
$1.80
Down-$0.02 (-0.83%)
Updated Aug 13, 2026, 8:08 PM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 52.73M
- P/E ratio
- -2.12
- Dividend yield
- 0.00%
- 52-week range
- $1.54 – $5.50
- Volume
- 502.31K
- Avg. volume
- 586.33K
Price performance
ANVS price history
1M range · 21 trading sessions · Daily adjusted prices
ANVS closed at $1.80 after 21 trading sessions, up 0.00% for the selected period.
- Last close
- $1.80
- Period change
- +0.00%
- Period low
- $1.66
- Period high
- $1.89
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 12, 2026 | $1.87 | $1.8962 | $1.80 | $1.80 | 502.31K |
| Aug 11, 2026 | $1.91 | $1.91 | $1.855 | $1.89 | 351.68K |
| Aug 10, 2026 | $1.90 | $1.90 | $1.85 | $1.89 | 321.13K |
| Aug 7, 2026 | $1.90 | $1.945 | $1.85 | $1.88 | 557.28K |
| Aug 6, 2026 | $1.91 | $1.91 | $1.81 | $1.86 | 317.22K |
| Aug 5, 2026 | $1.90 | $1.976 | $1.86 | $1.87 | 1.1M |
| Aug 4, 2026 | $1.75 | $1.905 | $1.72 | $1.87 | 808.97K |
| Aug 3, 2026 | $1.78 | $1.82 | $1.71 | $1.72 | 460.2K |
| Jul 31, 2026 | $1.81 | $1.81 | $1.70 | $1.75 | 353.01K |
| Jul 30, 2026 | $1.72 | $1.79 | $1.715 | $1.77 | 389.21K |
| Jul 29, 2026 | $1.67 | $1.755 | $1.67 | $1.70 | 567.92K |
| Jul 28, 2026 | $1.67 | $1.70 | $1.55 | $1.69 | 719.39K |
| Jul 27, 2026 | $1.69 | $1.715 | $1.63 | $1.67 | 499.66K |
| Jul 24, 2026 | $1.735 | $1.76 | $1.64 | $1.66 | 1.03M |
| Jul 23, 2026 | $1.70 | $1.76 | $1.69 | $1.75 | 630.75K |
| Jul 22, 2026 | $1.72 | $1.765 | $1.72 | $1.74 | 317.36K |
| Jul 21, 2026 | $1.72 | $1.77 | $1.69 | $1.75 | 364.43K |
| Jul 20, 2026 | $1.70 | $1.74 | $1.66 | $1.69 | 620.24K |
| Jul 17, 2026 | $1.71 | $1.785 | $1.70 | $1.74 | 624.2K |
| Jul 16, 2026 | $1.77 | $1.80 | $1.72 | $1.74 | 475.81K |
| Jul 15, 2026 | $1.72 | $1.825 | $1.7101 | $1.80 | 465.3K |
Latest ANVS news
The latest Smart Investors Daily articles mentioning ANVS.
Stock researchCompany · Financials
Loading stock research…